The Impact of Pharmacovigilance Sensitization Programme in Medical Students in a Tertiary Care Hospital in India

Abstract

protecting the health of the patients by assuring drug safety with well-defined goals to ensure its future growth and progress. Initially its National Coordinating Centre was at AIIMS, New Delhi but now it has been shifted to IPC Ghaziabad, UP. The prime activity of the Pharmacovigilance Program of India (PvPI) is to collect, collate and analyse data on adverse drug Studies have revealed that ADRs are a leading cause of hospitalization among the population and constitutes a significant economic burden on patients in our country (2). The World Health Organisation (WHO)defined theAdverse Drug Reactions (ADR) or adverse reaction as a response to a medicine used in humans or animals, which is noxious and unintended, including lack of efficacy, and which occurs at any dosage and can also result fro overdose, misuse or abuse of a medicine (1). The foundation of pharmacovigilance was laid on the following aims as specified by the WHO such as,the detection of increase in frequency of reported reactions, identification and quantification of risk factors and preventing the patients from being affected unnecessarily.

Adverse drug reactions reporting: Five years analysis from a teaching hospital

“…The sensitization and awareness programs at various tertiary hospitals across India have shown appreciable impact on the pharmacovigilance and ADR reporting. [ 10 11 ]…”